Literature DB >> 17563671

The efficacy and outcomes of urgent superselective transcatheter arterial embolization of patients with ruptured renal angiomyolipomas.

Ying-Hsu Chang1, Li-Jen Wang, Cheng-Keng Chuang, Yon-Cheong Wong, Chun-Te Wu, Ming-Li Hsieh.   

Abstract

BACKGROUND: To assess the efficacy and outcomes of urgent superselective transcatheter arterial embolization for emergency patients with ruptured renal angiomyolipomas.
METHODS: During a 49-month period, all emergency patients with ruptured angiomyolipomas that underwent urgent superselective transcatheter arterial embolization within the first 24 hours of admission were enrolled in this study. In each case, clinical presentation, trauma history, success or failure of embolization, presence of postembolization syndrome, and the necessity of subsequent emergency surgery of nephron-sparing surgery, and partial or total nephrectomy were recorded and analyzed.
RESULTS: The sample population consisted of seven female patients with ruptured angiomyolipomas; mean age was 48 years. The initial presenting symptoms were flank pain (n = 7), hematuria (n = 5), and lower hematocrit (Hb <10; n = 7). All individuals had received blood transfusion before the embolization. Two were traffic crash victims admitted in shock. Successful embolization was achieved in all cases; however, postembolization syndrome was noted in four. There was no requirement for emergent surgery after embolization.
CONCLUSIONS: Urgent superselective transcatheter arterial embolization was an effective treatment for our sample of emergency patients with ruptured renal angiomyolipomas where conservative supportive treatments had failed. There was no need of emergency surgery after embolization.

Entities:  

Mesh:

Year:  2007        PMID: 17563671     DOI: 10.1097/01.ta.0000221051.68550.4a

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  10 in total

Review 1.  The Role of Interventional Radiology Techniques in the Management of Renal Angiomyolipomas.

Authors:  Ryan M Kiefer; S William Stavropoulos
Journal:  Curr Urol Rep       Date:  2017-05       Impact factor: 3.092

Review 2.  Renal artery embolization-indications, technical approaches and outcomes.

Authors:  Arnaud Muller; Olivier Rouvière
Journal:  Nat Rev Nephrol       Date:  2014-12-23       Impact factor: 28.314

3.  Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma.

Authors:  Cheng-Keng Chuang; Hsin Chia Angela Lin; Han-Yu Tasi; Kun-Han Lee; Yuting Kao; Fukai Leo Chuang; Ying-Hsu Chang; Po-Hung Lin; Chung-Yi Liu; See-Tong Pang
Journal:  Int Urol Nephrol       Date:  2017-05-25       Impact factor: 2.370

Review 4.  Evidence-based protocol-led management of renal angiomyolipoma: A review of literature.

Authors:  Sophie Vaggers; Patrick Rice; Bhaskar K Somani; Rajan Veeratterapillay; Bhavan P Rai
Journal:  Turk J Urol       Date:  2020-09-21

5.  Long-term results of preventive embolization of renal angiomyolipomas: evaluation of predictive factors of volume decrease.

Authors:  A Hocquelet; F Cornelis; Y Le Bras; M Meyer; E Tricaud; A S Lasserre; J M Ferrière; G Robert; N Grenier
Journal:  Eur Radiol       Date:  2014-06-03       Impact factor: 5.315

6.  Urgent arterial embolization of ruptured renal angiomyolipoma.

Authors:  Selim Kervancioglu; Feyza Yilmaz
Journal:  Open Med (Wars)       Date:  2015-04-02

7.  Deep Learning Plus Three-Dimensional Printing in the Management of Giant (>15 cm) Sporadic Renal Angiomyolipoma: An Initial Report.

Authors:  Yunliang Gao; Yuanyuan Tang; Da Ren; Shunhua Cheng; Yinhuai Wang; Lu Yi; Shuang Peng
Journal:  Front Oncol       Date:  2021-11-15       Impact factor: 6.244

8.  Ruptured angiomyolipoma, a novel entity for emergency physicians in the differential diagnosis of haemorrhagic shock in a female patient of reproductive age.

Authors:  Abby Jo Sapadin; Daniel Girzadas; Darshika Chhabra; Tasneem Ahmed
Journal:  BMJ Case Rep       Date:  2022-08-09

9.  Interventional treatment of renal angiomyolipoma: immediate results and clinical and radiological follow-up of 4.5 years.

Authors:  Poul Erik Andersen; Mie Gaedt Thorlund; Gjertrud Egge Wennevik; Rune Lau Pedersen; Lars Lund
Journal:  Acta Radiol Open       Date:  2015-07-13

Review 10.  Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?

Authors:  Samy L Habib; Noor Y Al-Obaidi; Maciej Nowacki; Katarzyna Pietkun; Barbara Zegarska; Tomasz Kloskowski; Wojciech Zegarski; Tomasz Drewa; Edward A Medina; Zhenze Zhao; Sitai Liang
Journal:  J Cancer       Date:  2016-07-21       Impact factor: 4.207

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.